Informatie:
Fout:
ID
18701
Beschrijving
Irbesartan for the Prevention of Atrial Arrhythmias and Cardiac Electrical Remodeling in Patients With Hypertension and Permanent Pacemakers; ODM derived from: https://clinicaltrials.gov/show/NCT00225667
Link
https://clinicaltrials.gov/show/NCT00225667
Trefwoorden
Versies (1)
- 16-11-16 16-11-16 -
Geüploaded op
16 november 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Atrial Fibrillation NCT00225667
Eligibility Atrial Fibrillation NCT00225667
- StudyEvent: Eligibility
Similar models
Eligibility Atrial Fibrillation NCT00225667
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
sinus node dysfunction
Item
sinus node dysfunction (with or without av conduction disturbance)
boolean
C0428908 (UMLS CUI [1])
permanent pacemaker
Item
permanent, atrial or dual-chamber pacemaker implanted > 2 months before enrollment and with ability to record and store atrial high-rate episodes, frequency of mode switches and to perform non-invasive electrophysiologic testing
boolean
C0281945 (UMLS CUI [1])
Atrial high rate episodes
Item
history of at least 6 ahre in the last 6 months (rate > 220/min, duration of > 2 minutes
boolean
C0546959 (UMLS CUI [1])
Hypertension
Item
history of prior diagnosis of hypertension and/or treated for hypertension or two documented bp > 130/85 (measurements done at least one week apart)
boolean
C0020538 (UMLS CUI [1])
Atrial fibrillation
Item
permanent or persistent af or more than 6 episodes of symptomatic paroxysmal af in the previous 6 months
boolean
C0004238 (UMLS CUI [1])
Creatinine, Potassium
Item
documented cr >200 umol/l and k+ >5.2 mmol/l in the previous 3 months
boolean
C0201976 (UMLS CUI [1])
C0202194 (UMLS CUI [2])
C0202194 (UMLS CUI [2])
potassium sparing diuretic
Item
current treatment with a potassium sparing diuretic, unless serum potassium known to be in the normal range
boolean
C0304490 (UMLS CUI [1])
LVEF
Item
lv ejection fraction known to be < 40 %
boolean
C0428772 (UMLS CUI [1])
mitral regurgitation
Item
moderate or severe mitral regurgitation (3+, 4 +)
boolean
C0026266 (UMLS CUI [1])
mitral stenosis
Item
mitral stenosis of more than mild severity
boolean
C0026269 (UMLS CUI [1])
aortic stenosis
Item
aortic stenosis with mean gradient of > 25 mmhg
boolean
C0003507 (UMLS CUI [1])
Unstable Angina, CCS class
Item
angina at rest in the last 2 months, or current ccs class 3 or 4 angina
boolean
C0002965 (UMLS CUI [1])
C1879987 (UMLS CUI [2])
C1879987 (UMLS CUI [2])
unipolar atrial lead
Item
unipolar atrial lead
boolean
C2016199 (UMLS CUI [1])
av node ablation
Item
previous av node ablation
boolean
C3275044 (UMLS CUI [1])
p-wave amplitude
Item
p-wave amplitude less than 1.5 mv
boolean
C3900074 (UMLS CUI [1])
ace inhibitor, arb or aldosterone antagonist
Item
current therapy with an ace inhibitor, arb or aldosterone antagonist
boolean
C0003015 (UMLS CUI [1])
C0521942 (UMLS CUI [2])
C0002007 (UMLS CUI [3])
C0521942 (UMLS CUI [2])
C0002007 (UMLS CUI [3])
anti-arrhythmic medication (amiodarone, sotalol, flecainide, propafenone, quinidine, dofetilide)
Item
current or planned (within 6 months) with an anti-arrhythmic medication (amiodarone, sotalol, flecainide, propafenone, quinidine, dofetilide)
boolean
C0002598 (UMLS CUI [1])
C0037707 (UMLS CUI [2])
C0016229 (UMLS CUI [3])
C0033429 (UMLS CUI [4])
C0034414 (UMLS CUI [5])
C0114771 (UMLS CUI [6])
C0037707 (UMLS CUI [2])
C0016229 (UMLS CUI [3])
C0033429 (UMLS CUI [4])
C0034414 (UMLS CUI [5])
C0114771 (UMLS CUI [6])